The hyper-CVAD–rituximab chemotherapy programme followed by high-dose busulfan, melphalan and autologous stem cell transplantation produces excellent event-free survival in patients with previously untreated mantle cell lymphoma
| Image |  |
|---|---|
| Description | scientific article published on 07 November 2006 |
| Author/s |
author: Andrew W. Roberts Jeff Szer |
| Publication date | November 7, 2006 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |